These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9772323)

  • 41. Compliance with malaria chemoprophylaxis and preventative measures against mosquito bites among Dutch travellers.
    Cobelens FG; Leentvaar-Kuijpers A
    Trop Med Int Health; 1997 Jul; 2(7):705-13. PubMed ID: 9270740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Compliance of malaria chemoprophylaxis among travelers to India.
    Chatterjee S
    J Travel Med; 1999 Mar; 6(1):7-11. PubMed ID: 10071366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
    DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA
    J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spanish travelers to high-risk areas in the tropics: airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention.
    Lopez-Velez R; Bayas JM
    J Travel Med; 2007; 14(5):297-305. PubMed ID: 17883460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imported Plasmodium falciparum malaria in American travelers to Africa. Implications for prevention strategies.
    Lackritz EM; Lobel HO; Howell BJ; Bloland P; Campbell CC
    JAMA; 1991 Jan; 265(3):383-5. PubMed ID: 1984539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Malaria chemoprophylaxis for multiple drug resistant Plasmodium falciparum in Africa: an increasing problem.
    van der Kaay HJ; Overbosch D; Stuiver PC; Wismans PJ
    Trop Geogr Med; 1984 Dec; 36(4):317-22. PubMed ID: 6396911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From the Centers for Disease Control. Recommendations for the prevention of malaria among travelers.
    JAMA; 1990 May 23-30; 263(20):2729, 2734, 2737 passim. PubMed ID: 2159078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recommendations for the prevention of malaria among travelers.
    MMWR Recomm Rep; 1990 Mar; 39(RR-3):1-10. PubMed ID: 2156146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Problems in prescribing malaria chemoprophylaxis for travelers.
    Dupouy-Camet J; Yera H; Tourte-Schaeffer C
    Fundam Clin Pharmacol; 2003 Apr; 17(2):161-9. PubMed ID: 12667226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prophylaxis of malaria].
    Charmot G; Coulaud JP
    Presse Med; 1990 Dec 22-29; 19(44):2026-30. PubMed ID: 2148615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review: Malaria chemoprophylaxis for travelers to Latin America.
    Steinhardt LC; Magill AJ; Arguin PM
    Am J Trop Med Hyg; 2011 Dec; 85(6):1015-24. PubMed ID: 22144437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compliance with antimalarial chemoprophylaxis and the subsequent development of malaria: a matched case-control study.
    Gyorkos TW; Svenson JE; Maclean JD; Mohamed N; Remondin MH; Franco ED
    Am J Trop Med Hyg; 1995 Nov; 53(5):511-7. PubMed ID: 7485709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failure of atovaquone-proguanil chemoprophylaxis and chloroquine treatment in Plasmodium malariae infection.
    Visser R; de Mast Q; Munnix I; van der Ven A; Dofferhoff T
    Travel Med Infect Dis; 2016; 14(6):644-645. PubMed ID: 27546283
    [No Abstract]   [Full Text] [Related]  

  • 56. Antimalarial chemoprophylaxis in infants and children.
    Kramer MH; Lobel HO
    Paediatr Drugs; 2001; 3(2):113-21. PubMed ID: 11269638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimalarial chemoprophylaxis for west Africa.
    Basco LK; Le Bras J
    Lancet; 1993 Apr; 341(8849):902-3. PubMed ID: 8096609
    [No Abstract]   [Full Text] [Related]  

  • 58. Malaria prophylaxis in travelers.
    Wolff JA; Smith RP
    J Fam Pract; 1980 Nov; 11(6):879-82. PubMed ID: 7005388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. From the Centers for Disease Control and Prevention. Malaria deaths following inappropriate malaria chemoprophylaxis--United States, 2001.
    JAMA; 2001 Aug; 286(7):783-4. PubMed ID: 11519496
    [No Abstract]   [Full Text] [Related]  

  • 60. Arguments against Chemoprophylaxis in Areas at Low Risk for Chloroquine-Resistant Plasmodium falciparum.
    Armengaud M
    J Travel Med; 1995 Mar; 2(1):4-5. PubMed ID: 9815351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.